RJT
CME icon

Raymond James Trust’s CME Group CME Stock Holding History

Raymond James Trust’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$7.89M Sell
35,747
-2,783
-7% -$576K 0.17% 117
2024
Q2 		$7.58M Buy
38,530
+2,163
+6% +$447K 0.18% 116
2024
Q1 		$7.83M Buy
36,367
+788
+2% +$166K 0.19% 113
2023
Q4 		$7.49M Buy
35,579
+4,685
+15% +$1,000K 0.2% 116
2023
Q3 		$6.19M Sell
30,894
-1,388
-4% -$276K 0.18% 122
2023
Q2 		$5.98M Sell
32,282
-2,245
-7% -$415K 0.17% 127
2023
Q1 		$6.61M Sell
34,527
-5,197
-13% -$940K 0.21% 107
2022
Q4 		$6.68M Buy
39,724
+1,374
+4% +$239K 0.22% 107
2022
Q3 		$6.79M Buy
38,350
+444
+1% +$87.7K 0.25% 95
2022
Q2 		$7.76M Buy
37,906
+4,097
+12% +$868K 0.28% 86
2022
Q1 		$8.04M Sell
33,809
-993
-3% -$233K 0.25% 97
2021
Q4 		$7.95M Buy
34,802
+1,165
+3% +$256K 0.24% 97
2021
Q3 		$6.5M Buy
33,637
+1,063
+3% +$215K 0.22% 102
2021
Q2 		$6.93M Sell
32,574
-222
-0.7% -$46.9K 0.23% 99
2021
Q1 		$6.7M Buy
32,796
+5,295
+19% +$1.04M 0.23% 98
2020
Q4 		$5.01M Sell
27,501
-306
-1% -$52K 0.19% 114
2020
Q3 		$4.65M Buy
27,807
+952
+4% +$160K 0.2% 112
2020
Q2 		$4.37M Buy
26,855
+3,873
+17% +$694K 0.21% 107
2020
Q1 		$3.97M Buy
22,982
+1,490
+7% +$297K 0.24% 98
2019
Q4 		$4.31M Sell
21,492
-1,218
-5% -$250K 0.21% 106
2019
Q3 		$4.8M Buy
22,710
+1,658
+8% +$346K 0.25% 96
2019
Q2 		$4.09M Buy
21,052
+117
+0.6% +$21.6K 0.23% 100
2019
Q1 		$3.44M Buy
20,935
+1,920
+10% +$339K 0.2% 115
2018
Q4 		$3.58M Buy
19,015
+555
+3% +$102K 0.23% 102
2018
Q3 		$3.14M Buy
18,460
+605
+3% +$102K 0.18% 126
2018
Q2 		$2.93M Buy
17,855
+971
+6% +$159K 0.18% 123
2018
Q1 		$2.73M Buy
16,884
+1,325
+9% +$211K 0.19% 121
2017
Q4 		$2.27M Buy
15,559
+804
+5% +$115K 0.15% 147
2017
Q3 		$2M Buy
14,755
+427
+3% +$53.9K 0.14% 157
2017
Q2 		$1.79M Buy
14,328
+356
+3% +$42.6K 0.13% 167
2017
Q1 		$1.66M Buy
13,972
+631
+5% +$75.9K 0.13% 171
2016
Q4 		$1.54M Sell
13,341
-2,344
-15% -$261K 0.12% 177
2016
Q3 		$1.64M Sell
15,685
-500
-3% -$52.2K 0.14% 154
2016
Q2 		$1.58M Buy
16,185
+686
+4% +$64.8K 0.14% 156
2016
Q1 		$1.49M Sell
15,499
-1,586
-9% -$144K 0.14% 153
2015
Q4 		$1.55M Buy
17,085
+3,169
+23% +$298K 0.14% 155
2015
Q3 		$1.29M Buy
13,916
+840
+6% +$79.8K 0.15% 146
2015
Q2 		$1.22M Buy
13,076
+1,348
+11% +$126K 0.13% 166
2015
Q1 		$1.11M Sell
11,728
-2,511
-18% -$233K 0.12% 181
2014
Q4 		$1.26M Buy
14,239
+558
+4% +$47.3K 0.14% 163
2014
Q3 		$1.09M Sell
13,681
-80
-0.6% -$6.03K 0.13% 176
2014
Q2 		$975K Sell
13,761
-102
-0.7% -$7.18K 0.11% 188
2014
Q1 		$1.03M Buy
13,863
+1,190
+9% +$89.8K 0.13% 170
2013
Q4 		$994K Buy
12,673
+1,630
+15% +$128K 0.13% 164
2013
Q3 		$815K Buy
11,043
+819
+8% +$60.3K 0.13% 176
2013
Q2 		$777K Buy
+10,224
New +$671K 0.13% 170

Other funds holding CME

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Raymond James Trust's CME Position: Q3 2024 in Review

Raymond James Trust reduced its CME Group (CME) stake by 7.2% in Q3 2024, selling an estimated $576K and leaving 35,747 shares worth $7.89M. The position accounts for 0.17% of the portfolio, ranked #117.

Raymond James Trust first reported a position in CME in Q2 2013 and has held it in 46 quarters since. The position peaked at $8.04M in Q1 2022. 1,390 funds tracked by Wall St. Rank hold CME as of Q3 2024.

  • Raymond James Trust held 35,747 shares of CME Group worth $7.89M as of Q3 2024.
  • Raymond James Trust sold 2,783 CME Group shares in Q3 2024, an estimated $576K.
  • CME Group made up 0.17% of Raymond James Trust's portfolio in Q3 2024, its #117 holding.
  • Raymond James Trust first reported a position in CME Group in Q2 2013 and has held it in 46 quarters since.
  • Raymond James Trust's CME Group position peaked at $8.04M in Q1 2022.
  • 1,390 funds tracked by Wall St. Rank held CME Group as of Q3 2024.

Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.